GLP-1 and Keytruda steamed ahead in Q3

The report season is in full bloom. In the Big Pharma space, diabetes and obesity remain in focus during the third quarter, while world leader Keytruda enjoys a continued success story. BioStock has taken a closer look at the period.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/11/glp-1-and-keytruda-steamed-ahead-in-q3/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se